A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT04696809 · COMPLETED
Trial details
- NCT number
- NCT04696809
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-22
- Primary completion
- 2026-04-13
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.